fruticuline A: isolated from Salvia corrugata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Salvia | genus | A genus in the mint family (LAMIACEAE).[MeSH] | Lamiaceae | The mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 362046 |
| MeSH ID | M0534286 |
| Synonym |
|---|
| fruticulin a |
| nsc-625555 |
| 106664-40-8 |
| nsc625555 |
| 1h-dibenzo[a,4(10h)-dione, 3-hydroxy-7-methoxy-9-methyl-2-(1-methylethyl)- |
| 2-hydroxy-3-isopropyl-9-methoxy-7-methyl-6h-dibenzo[[?],[?]][7]annulene-1,4-dione |
| {1h-dibenzo[a,d]cycloheptene-1,4(10h)-dione,} 3-hydroxy-7-methoxy-9-methyl-2-(1-methylethyl)- |
| 3-hydroxy-2-isopropyl-7-methoxy-9-methyl-1h-dibenzo[a,d]cycloheptene-1,4(10h)-dione |
| fys7rqn2q8 , |
| 3-hydroxy-2-isopropyl-7-methoxy-9-methyl-1h-dibenzo(a,d)cycloheptene-1,4(10h)-dione |
| unii-fys7rqn2q8 |
| nsc 625555 |
| 1h-dibenzo(a,d)cycloheptene-1,4(10h)-dione, 3-hydroxy-7-methoxy-9-methyl-2-(1-methylethyl)- |
| fruticuline a |
| 3-hydroxy-7-methoxy-9-methyl-2-(propan-2-yl)-1h-dibenzo[a,d][7]annulene-1,4(10h)-dione |
| DTXSID80910072 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.28) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||